Association of HbA1c with Time in Range, Time in Tight Range, Empirically Derived Continuous Glucose Monitoring Glucose Ranges, and Mean Glucose.

IF 7.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Halis Kaan Akturk, Kagan E Karakus, Emma Mason, Zeynep Y Yilmaz, Satish K Garg, Dicle Cengiz
{"title":"Association of HbA1c with Time in Range, Time in Tight Range, Empirically Derived Continuous Glucose Monitoring Glucose Ranges, and Mean Glucose.","authors":"Halis Kaan Akturk, Kagan E Karakus, Emma Mason, Zeynep Y Yilmaz, Satish K Garg, Dicle Cengiz","doi":"10.1177/15209156261496613","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate how continuous glucose monitoring (CGM) glucose thresholds, sampling duration, and statistical modeling influence associations between CGM-derived range metrics and HbA1c, and to compare empirically derived glucose ranges with time in range (TIR) and time in tight range (TITR).</p><p><strong>Research design and methods: </strong>Out of 8160 HbA1c-matched CGM datasets from 1584 adults, CGM data from the 14, 30, and 90 days preceding each HbA1c measurement were evaluated. Associations between HbA1c and 7790 CGM glucose ranges were assessed across varying lower and upper glucose thresholds. Linear and log-linear mixed-effects models adjusted for age and race with participant-level random intercepts were compared using root mean square error and marginal <i>R</i><sup>2</sup>. Participant-level derivation (80%) and validation (20%) cohorts were used for cross-validated threshold selection and discrimination analyses for HbA1c ≤7.0%.</p><p><strong>Results: </strong>Ninety-day CGM sampling showed the strongest associations with HbA1c. Log-linear models frequently provided comparable or improved fit, particularly for glucose ranges with upper thresholds below 180 mg/dL. Stronger HbA1c associations clustered around upper glucose thresholds of 155-175 mg/dL. In validation analyses, empirically derived ranges demonstrated strong discrimination of HbA1c ≤7.0% (area under the receiver operating characteristic curve [AUC] 0.909-0.915), compared with 0.903 for TIR and 0.905 for TITR, although absolute differences were small. Mean glucose demonstrated the strongest explanatory performance for continuous HbA1c (marginal <i>R</i><sup>2</sup> = 0.74) and similarly strong discrimination (AUC 0.913).</p><p><strong>Conclusions: </strong>CGM-HbA1c relationships are influenced by glucose range, sampling duration, and statistical modeling. Our findings reinforce TIR and TITR as robust CGM metrics with strong associations with HbA1c, while also showing that selected empirically derived glucose ranges can provide modestly stronger statistical alignment. These results support the continued use of TIR and TITR while highlighting how glucose range definition may refine interpretation of CGM-based endpoints in future research.</p>","PeriodicalId":11159,"journal":{"name":"Diabetes technology & therapeutics","volume":" ","pages":"15209156261496613"},"PeriodicalIF":7.4000,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes technology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15209156261496613","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To evaluate how continuous glucose monitoring (CGM) glucose thresholds, sampling duration, and statistical modeling influence associations between CGM-derived range metrics and HbA1c, and to compare empirically derived glucose ranges with time in range (TIR) and time in tight range (TITR).

Research design and methods: Out of 8160 HbA1c-matched CGM datasets from 1584 adults, CGM data from the 14, 30, and 90 days preceding each HbA1c measurement were evaluated. Associations between HbA1c and 7790 CGM glucose ranges were assessed across varying lower and upper glucose thresholds. Linear and log-linear mixed-effects models adjusted for age and race with participant-level random intercepts were compared using root mean square error and marginal R2. Participant-level derivation (80%) and validation (20%) cohorts were used for cross-validated threshold selection and discrimination analyses for HbA1c ≤7.0%.

Results: Ninety-day CGM sampling showed the strongest associations with HbA1c. Log-linear models frequently provided comparable or improved fit, particularly for glucose ranges with upper thresholds below 180 mg/dL. Stronger HbA1c associations clustered around upper glucose thresholds of 155-175 mg/dL. In validation analyses, empirically derived ranges demonstrated strong discrimination of HbA1c ≤7.0% (area under the receiver operating characteristic curve [AUC] 0.909-0.915), compared with 0.903 for TIR and 0.905 for TITR, although absolute differences were small. Mean glucose demonstrated the strongest explanatory performance for continuous HbA1c (marginal R2 = 0.74) and similarly strong discrimination (AUC 0.913).

Conclusions: CGM-HbA1c relationships are influenced by glucose range, sampling duration, and statistical modeling. Our findings reinforce TIR and TITR as robust CGM metrics with strong associations with HbA1c, while also showing that selected empirically derived glucose ranges can provide modestly stronger statistical alignment. These results support the continued use of TIR and TITR while highlighting how glucose range definition may refine interpretation of CGM-based endpoints in future research.

HbA1c与范围内时间、窄范围时间、经验性连续血糖监测范围和平均血糖的关系
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes technology & therapeutics
Diabetes technology & therapeutics 医学-内分泌学与代谢
CiteScore
10.60
自引率
14.80%
发文量
145
审稿时长
3-8 weeks
期刊介绍: Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书